GlassScriptPhysician profile
Michelle NP Parish
NPI 1003302639
$1,844.29
in general payments reported to CMS, 2019-2025
17 companies · $1,087 in 2025
The $1,087 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $248 · 2022: $56.39 · 2023: $270 · 2024: $183 · 2025: $1,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,539.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $873.51 | 2024-2025 | Intracept, Wavewriter Alpha Prime 16, Na |
| Globus Medical, INC. | $148.21 | 2025 | Senza |
| Collegium Pharmaceutical, INC. | $146.75 | 2021-2023 | Belbuca |
| Nevro Corp. | $124.17 | 2021-2024 | Senza |
| Nalu Medical, INC. | $97.78 | 2021-2023 | Nalu Neurostimulation System |
| Novo Nordisk INC | $87.13 | 2025 | Wegovy |
| Abbvie INC. | $69.08 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.44 | 2023 | Relistor |
| Scilex Pharmaceuticals INC. | $51.03 | 2021-2024 | |
| Averitas Pharma INC. | $46.00 | 2023 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $37.71 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.87 | 2022 | |
| Si-Bone, INC. | $19.34 | 2024 | |
| Redhill Biopharma INC. | $18.06 | 2022 | |
| Pacira Therapeutics, INC. | $16.99 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Virtus Pharmaceuticals LLC | $13.42 | 2021 | |
| Biodelivery Sciences International, INC. | $11.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Parish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.